Reports Q3 revenue $151M, consensus $147.2M. “At ATEC, our commitment continues to be to enhance spine care through innovation,” said Pat Miles, Chairman and Chief Executive Officer. “That commitment has fueled growth at multiples of our industry for over five years. We recognize the importance of converting growth to expand profitability so we can support our long-term vision, and we are actively executing internal initiatives to impact cash flow. Our view of the opportunity ahead is unchanged: we are building a special company that is uniquely positioned to revolutionize spine care.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ATEC:
- Is ATEC a Buy, Before Earnings?
- Needham medtech & diagnostics analyst holds analyst/industry conference call
- Lake Street trims Alphatec price target, says time to ‘buy shares aggressively’
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
%20%7C%20Nasdaq&_biz_n=13&rnd=357369&cdn_o=a&_biz_z=1743729255556)
%2C%20consensus%20(25c)%20%7C%20Nasdaq&_biz_n=16&rnd=654559&cdn_o=a&_biz_z=1743729255556)
%2C%20consensus%20(25c)%20%7C%20Nasdaq&rnd=683437&cdn_o=a&_biz_z=1743729255561)